BASF Signs Letter of Intent to Supply Neopentyl Glycol to KHUA
By Giulia Petroni
BASF has signed a letter of intent to supply neopentyl glycol from its Zhanjiang Verbund site in China to Zhejiang Guanghua Technology.
The German chemical company said Wednesday that Zhejiang Guanghua Technology, also known as KHUA, plans to build a 100,000-tons-a-year production plant for powder coating resins in Donghai Island, where BASF is building a neopentyl glycol plant.
"This strategic move will create synergies that benefit both parties, including enhanced collaboration and supply reliability, faster delivery, access to shared resources, and reduced costs," said Vasilios Galanos, senior vice president, intermediates Asia Pacific at BASF.
The plant at the Zhanjiang Verbund site is expected to be available from the fourth quarter of 2025, BASF said. The company added that its global neopentyl glycol capacity will be boosted to 335,000 metric tons annually from 255,000 metric tons.
Write to Giulia Petroni at giulia.petroni@wsj.com
(END) Dow Jones Newswires
July 12, 2023 03:58 ET (07:58 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
Six Sports Betting and iGaming Stocks Trading at a Discount
-
4 Predictions for Stocks and the Economy for the Second Half of 2024
-
What Broadening Rally? AI Stocks Dominate Again In Q2
-
After Earnings, Is Nike Stock a Buy, a Sell, or Fairly Valued?
-
Worst-Performing Stock ETFs of the Quarter
-
Top-Performing Stock ETFs of the Quarter
-
Q2 In Review and Q3 2024 Market Outlook
-
5 Stocks to Buy for 3Q 2024
-
Industrials: Sector Offers Investment Opportunities as Performance Lags Broader Market
-
Consumer Defensives: Even Amid Macro Pressures, Deals Permeate the Landscape
-
33 Undervalued Stocks
-
Utilities: Can the Stocks Keep the Rally Going?
-
Basic Materials: Following Index Decline, We See Many Long-Term Opportunities
-
Healthcare: Valuations Look Attractive In Most Industries
-
Financial Services: Amid Uncertainties, We See the Most Value In Banks and Credit Services
-
Consumer Cyclicals: Even With Anxiety Over Spending, We See Attractive Valuations